159 related articles for article (PubMed ID: 38358572)
1. The built-in selection bias of hazard ratios formalized using structural causal models.
Post RAJ; van den Heuvel ER; Putter H
Lifetime Data Anal; 2024 Apr; 30(2):404-438. PubMed ID: 38358572
[TBL] [Abstract][Full Text] [Related]
2. Bias of the additive hazard model in the presence of causal effect heterogeneity.
Post RAJ; van den Heuvel ER; Putter H
Lifetime Data Anal; 2024 Apr; 30(2):383-403. PubMed ID: 38466520
[TBL] [Abstract][Full Text] [Related]
3. Causal interpretation of the hazard ratio in randomized clinical trials.
Fay MP; Li F
Clin Trials; 2024 Apr; ():17407745241243308. PubMed ID: 38679930
[TBL] [Abstract][Full Text] [Related]
4. A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies.
Axelrod R; Nevo D
Biometrics; 2023 Sep; 79(3):2743-2756. PubMed ID: 36385393
[TBL] [Abstract][Full Text] [Related]
5. Comparison of statistical methods for the analysis of recurrent adverse events in the presence of non-proportional hazards and unobserved heterogeneity: a simulation study.
Patson N; Mukaka M; Kazembe L; Eijkemans MJC; Mathanga D; Laufer MK; Chirwa T
BMC Med Res Methodol; 2022 Jan; 22(1):24. PubMed ID: 35057743
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. How hazardous are hazard ratios? An empirical investigation of individual patient data from 27 large randomized clinical trials.
Strobel A; Wienke A; Kuss O
Eur J Epidemiol; 2023 Aug; 38(8):859-867. PubMed ID: 37410301
[TBL] [Abstract][Full Text] [Related]
8. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
Wang Y; Berlin JA; Pinheiro J; Wilcox MA
Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
[TBL] [Abstract][Full Text] [Related]
9. Clarifying selection bias in cluster randomized trials.
Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
[TBL] [Abstract][Full Text] [Related]
10. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
Hogan JW; Lancaster T
Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
[TBL] [Abstract][Full Text] [Related]
11. How serious is bias in effect estimation in randomised trials with survival data given risk heterogeneity and informative censoring?
McNamee R
Stat Med; 2017 Sep; 36(21):3315-3333. PubMed ID: 28621000
[TBL] [Abstract][Full Text] [Related]
12. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
Anglemyer A; Horvath HT; Bero L
Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322
[TBL] [Abstract][Full Text] [Related]
13. Subtleties in the interpretation of hazard contrasts.
Martinussen T; Vansteelandt S; Andersen PK
Lifetime Data Anal; 2020 Oct; 26(4):833-855. PubMed ID: 32654089
[TBL] [Abstract][Full Text] [Related]
14. Individual frailty excess hazard models in cancer epidemiology.
Rubio FJ; Putter H; Belot A
Stat Med; 2023 Mar; 42(7):1066-1081. PubMed ID: 36694108
[TBL] [Abstract][Full Text] [Related]
15. Exploring Selection Bias by Causal Frailty Models: The Magnitude Matters.
Stensrud MJ; Valberg M; Røysland K; Aalen OO
Epidemiology; 2017 May; 28(3):379-386. PubMed ID: 28244888
[TBL] [Abstract][Full Text] [Related]
16. Marginal hazard ratio estimates in joint frailty models for heart failure trials.
Toenges G; Jahn-Eimermacher A
Biom J; 2019 Nov; 61(6):1385-1401. PubMed ID: 31206775
[TBL] [Abstract][Full Text] [Related]
17. Estimating causal contrasts involving intermediate variables in the presence of selection bias.
Valeri L; Coull BA
Stat Med; 2016 Nov; 35(26):4779-4793. PubMed ID: 27411847
[TBL] [Abstract][Full Text] [Related]
18. On robustness of marginal regression coefficient estimates and hazard functions in multivariate survival analysis of family data when the frailty distribution is mis-specified.
Hsu L; Gorfine M; Malone K
Stat Med; 2007 Nov; 26(25):4657-78. PubMed ID: 17348081
[TBL] [Abstract][Full Text] [Related]
19. causalCmprsk: An R package for nonparametric and Cox-based estimation of average treatment effects in competing risks data.
Vakulenko-Lagun B; Magdamo C; Charpignon ML; Zheng B; Albers MW; Das S
Comput Methods Programs Biomed; 2023 Dec; 242():107819. PubMed ID: 37774426
[TBL] [Abstract][Full Text] [Related]
20. Correction of Selection Bias in Survey Data: Is the Statistical Cure Worse Than the Bias?
Hanley JA
Am J Epidemiol; 2017 Mar; 185(6):409-411. PubMed ID: 28399572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
